Annual Drug Patent Expirations for JYNARQUE
Jynarque is a drug marketed by Otsuka Pharm Co Ltd and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
Drug patent litigation for JYNARQUE.
This drug has sixty-four patent family members in nineteen countries.
The generic ingredient in JYNARQUE is tolvaptan. One supplier is listed for this compound. Additional details are available on the tolvaptan profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com